Cervical Cancer Trial, Recruiting NCT05950087 Sponsor: Guizhou Provincial People's Hospital Condition: Cervical Cancer
Back to Cervical Cancer

Cervical Cancer Trial, Recruiting

NCT05950087
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 75 years old.
  • People who have had cervical cancer confirmed through a tissue sample (biopsy or pathology test).
  • People who are able to have imaging scans such as PET/CT, and who are able to attend all required follow-up appointments.
  • People who have at least one measurable tumour present before treatment begins.
  • People in good general physical health, rated as functioning well on standard medical scoring scales (ECOG 0–1 or KPS 70–100) (confirm with trial site).
  • People whose doctors estimate they are likely to live for at least 6 months.
  • People whose blood test results before treatment meet specific levels, including: haemoglobin, white blood cell count, platelet count, liver enzyme levels, and protein levels all within the ranges required by the trial (confirm with trial site for exact values).
  • People who, if they have syphilis, have completed the required treatment for it before entering the trial.
  • People with no history of allergy to rubber products.
  • People whose heart and lung function is broadly normal.

Who may not be able to join:

  • People who have a known allergy to rubber products.
  • People with serious active infections, including uncontrolled or non-healing infected wounds, active hepatitis B, active tuberculosis, an active syphilis outbreak, or HIV/AIDS.
  • People with serious pre-existing heart conditions, such as heart failure, difficult-to-control irregular heartbeat, unstable chest pain (angina), previous heart attack, severe heart valve disease, or very difficult-to-control high blood pressure.
  • People with neurological or psychiatric conditions that are hard to manage, or who are unable to cooperate with or report on their treatment experience; also people with uncontrolled brain tumours or cancer that has spread to the brain, or signs of significant pressure in the skull.
  • People who have a build-up of fluid in body cavities caused by cancer (such as in the abdomen or chest).
  • People with a history of severe bowel or bladder inflammation, bleeding, bowel perforation, or abnormal passages (fistulas) between the bowel, vagina, or bladder.
  • People who are already taking part in another clinical trial.
  • People whom the trial investigators consider unsuitable for the trial for other reasons.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13628566285

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guizhou Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
1 November 2022
Est. completion
30 November 2024

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Expression levels of MRD; Positive expression of plasma HPV; Expression levels of MRD; Positive expression of plasma HPV; Expression levels of MRD; Positive expression of plasma HPV; Expression levels of MRD; Positive expression of plasma HPV; Expression levels of MRD; Positive expression of plasma HPV

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov